Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis
Breast cancer research has paved the way of personalized oncology with the introduction of hormonal therapy and the measurement of estrogen receptor as the first widely accepted clinical biomarker. The expression of another receptor—HER2/ERBB2/neu—was initially a sign of worse prognosis, but targete...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2013-08-01
|
| Series: | Microarrays |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2076-3905/2/3/228 |